Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Bladder Cancer
  •  Pancreatic Cancer
  •  Adjuvant Therapy
  •  Immunology
  •  Brain and Spinal Cord Cancer
  •  Endometrial Cancer
  •  Carcinomas
  •  Colorectal Cancer

Abstract

Citation: Clin Oncol. 2020;5(1):1690.DOI: 10.25107/2474-1663.1690

Primary Bilateral Adrenal NK/T Lymphoma Revealed by Hemophagocytic Syndrome - A Case Report and Literature Review

Tai-Gang Zhu, Xiao-Jiao Zhang, Yue-Hong Li, Fei-Hu Zhang1, Bing Wei, Hai Cheng

Department of Hematology, Wanbei Coal-elecricity General Hospital, China Department of Hematology, Affiliated Hospital of Xuzhou Medical University, China

*Correspondance to: Tai-Gang Zhu 

 PDF  Full Text Case Report | Open Access

Abstract:

Primary adrenal lymphoma is a malignant tumor that originates in lymph nodes and extranodal lymphoid tissues, but the adrenal gland has no lymphoid tissue, so the pathogenesis is not clear. NK/ T-cell lymphoma is a rapidly progressing hematological malignancy. Reports of primary adrenal NK/T-cell lymphoma are rare. On September 11, 2018, we first discovered a case of primary adrenal NK/T lymphoma with hemophagocytic syndrome as the first manifestation.

Keywords:

Primary adrenal lymphoma; NK/T-cell lymphoma; Hemophagocytic syndrome

Cite the Article:

Zhu T-G, Zhang X-J, Li Y-H, Zhang F-H, Wei B, Cheng Hai.. Primary Bilateral Adrenal NK/T Lymphoma Revealed by Hemophagocytic Syndrome - A Case Report and Literature Review. Clin Oncol. 2020; 5: 1690.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Clinical Outcome for Rectal Cancer Treated with Preoperative Chemoradiotherapy (CRT) Based on the Pathological Tumor Regression Grade (TRG)
 Abstract  PDF  Full Text
Examination of the Efficacy of Fulvestrant 500 mg Targeting Estrogen Receptor-Positive Postmenopausal Metastatic Breast Cancer: Prospective Observational Study (PerSeUS BC03 Study)
 Abstract  PDF  Full Text
View More...